IL-1β, IL-6, and RANTES as Biomarkers of Chikungunya Severity

被引:230
|
作者
Ng, Lisa F. P. [1 ]
Chow, Angela [2 ]
Sun, Yong-Jiang [2 ]
Kwek, Dyan J. C. [1 ]
Lim, Poh-Lian [2 ]
Dimatatac, Frederico [2 ]
Ng, Lee-Ching [3 ]
Ooi, Eng-Eong [4 ]
Choo, Khar-Heng [5 ]
Her, Zhisheng [1 ]
Kourilsky, Philippe [1 ]
Leo, Yee-Sin [2 ]
机构
[1] ASTAR, Singapore Immunol Network, Singapore, Singapore
[2] Tan Tock Seng Hosp, Communicable Dis Ctr, Singapore, Singapore
[3] Environm Hlth Inst, Singapore, Singapore
[4] DSO Natl Lab, Singapore, Singapore
[5] ASTAR, Inst Infocomm Res, Singapore, Singapore
来源
PLOS ONE | 2009年 / 4卷 / 01期
关键词
ACUTE RESPIRATORY SYNDROME; NATURAL-KILLER-CELLS; INDIAN-OCEAN; RHEUMATOID-ARTHRITIS; INTENSIVE-CARE; GROWTH-FACTOR; RISK-FACTORS; VIRUS; OUTBREAK; SEPSIS;
D O I
10.1371/journal.pone.0004261
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Little is known about the immunopathogenesis of Chikungunya virus. Circulating levels of immune mediators and growth factors were analyzed from patients infected during the first Singaporean Chikungunya fever outbreak in early 2008 to establish biomarkers associated with infection and/or disease severity. Methods and Findings: Adult patients with laboratory-confirmed Chikungunya fever infection, who were referred to the Communicable Disease Centre/Tan Tock Seng Hospital during the period from January to February 2008, were included in this retrospective study. Plasma fractions were analyzed using a multiplex-microbead immunoassay. Among the patients, the most common clinical features were fever (100%), arthralgia (90%), rash (50%) and conjunctivitis (40%). Profiles of 30 cytokines, chemokines, and growth factors were able to discriminate the clinical forms of Chikungunya from healthy controls, with patients classified as non-severe and severe disease. Levels of 8 plasma cytokines and 4 growth factors were significantly elevated. Statistical analysis showed that an increase in IL-1b, IL-6 and a decrease in RANTES were associated with disease severity. Conclusions: This is the first comprehensive report on the production of cytokines, chemokines, and growth factors during acute Chikungunya virus infection. Using these biomarkers, we were able to distinguish between mild disease and more severe forms of Chikungunya fever, thus enabling the identification of patients with poor prognosis and monitoring of the disease.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Human Nucleus Pulposus Cells React to IL-6: Independent Actions and Amplification of Response to IL-1 and TNF-α
    Studer, Rebecca K.
    Vo, Nam
    Sowa, Gwendolyn
    Ondeck, Courtney
    Kang, James
    SPINE, 2011, 36 (08) : 593 - 599
  • [22] Arthritis severity locus Cia4 is an early regulator of IL-6, IL-1β, and NF-κB activators' expression in pristane-induced arthritis
    Brenner, Max
    Laragione, Teresina
    Gulko, Percio S.
    PHYSIOLOGICAL GENOMICS, 2013, 45 (13) : 552 - 564
  • [23] A Brief History of IL-1 and IL-1 Ra in Rheumatology
    Dayer, Jean-Michel
    Oliviero, Francesca
    Punzi, Leonardo
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [24] Correlation between plasma levels of D-dimer and IL-1, IL-6, and TNF-α in patients with rheumatoid arthritis
    Ma, Jingjing
    Zhang, Yanhui
    Gong, Yufang
    Zhu, Yun
    Li, Ming
    Zhao, Jinmei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (09): : 9865 - 9871
  • [25] Pathogenic roles of IL-6 and IL-6 blocking therapy on rheumatoid arthritis
    Yoshizaki, K
    Nishimoto, N
    Miyasaka, N
    Yamamoto, K
    Kawai, S
    Takeuchi, T
    Kishimoto, T
    ARTHRITIS RESEARCH & THERAPY, 2003, 5 (Suppl 3) : S42 - S42
  • [26] Increased expression of IL-1 receptors in response to IL-1β may produce more IL-6, IL-8, VEGF, and PGE2 in senescent synovial cells induced in vitro than in presenescent cells
    Park, Jina
    Choi, Hyun Mi
    Yang, Hyung-In
    Yoo, Myung Chul
    Kim, Kyoung Soo
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (07) : 2005 - 2010
  • [27] Pathogenic roles of IL-6 and IL-6 blocking therapy on rheumatoid arthritis
    K Yoshizaki
    N Nishimoto
    N Miyasaka
    K Yamamoto
    S Kawai
    T Takeuchi
    T Kishimoto
    Arthritis Res Ther, 5
  • [28] Effects of IL-6 and IL-6 blockade on neutrophil function in vitro and in vivo
    Wright, Helen L.
    Cross, Andrew L.
    Edwards, Steven W.
    Moots, Robert J.
    RHEUMATOLOGY, 2014, 53 (07) : 1321 - 1331
  • [29] Differential susceptibility to lethal endotoxaemia in mice deficient in IL-1α, IL-1β or IL-1 receptor type I
    Joosten, Leo A. B.
    van de Veerdonk, Frank L.
    Vonk, Alieke G.
    Boerman, Otto C.
    Keuter, Monique
    Fantuzzi, Giamilla
    Verschueren, Ineke
    van der Poll, Tom
    Dinarello, Charles A.
    Kullberg, Bart Jan
    Van der Meer, Jos W. M.
    Netea, Mihai G.
    APMIS, 2010, 118 (12) : 1000 - 1007
  • [30] Adenoviral transfer of murine OncostatinM induces inflammation and bone apposition in joints of IL-1, IL-6 and TNF-α deficient mice
    ASK de Hooge
    FAJ van de Loo
    M Bennink
    CD Richards
    OJ Arntz
    WB van den Berg
    Arthritis Research & Therapy, 4 (Suppl 1)